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INTRODUCTION
The paraneoplastic pemphigus (PNP) 
is a neoplasia-associated autoimmune disease. 
It is characterized by a polymorphic mucocuta-
neous eruption, and its differential diagnoses are: 
pemphigus vulgaris, multiform erythema, Steven 
Johnson’s syndrome and lichen planus1.
It was first described in 19902. PNP pa-
tients have reactive antibodies to desmoplakin and 
desmosomal plaque proteins present throughout 
their entire epithelium; thus, a more extensive 
involvement is not surprising3.
The goal of the present report is to pre-
sent a case of paraneoplastic pemphigus, which 
first manifestation were bullous lesions on the 
mucosae of the mouth, larynx and nasal septum.
CASE REPORT
A 68-year-old woman complaining of 
epistaxis and painful blisters in her mouth for 
thirty days, associated with dysphagia and weight 
loss - which she did not measure. She did not 
complain of skin lesions. She smoked and had 
blood hypertension, diabetes and dyslipidemia. 
Upon clinical exam she had ulcerated and bullous 
lesions on the palate, cheek mucosa (Figure 1) and 
lower lip, and also an ulceration on her anterior 
nasal septum.
She also had ulcerated lesions with fibrin 
in her larynx and bilateral chorditis, seen upon 
telelaryngoscopy. Thinking about pemphigus vul-
garis, she was started on prednisone, 40 mg/day 
and we biopsied the lesion on her cheek mucosa 
- which resulted inconclusive upon light micros-
copy and immunohistochemistry. After partial 
improvement only, the prednisone dose was 
increased to 60 mg/day.
She also developed bullous lesions in her 
genital and periungual areas, and at this point a 
new biopsy was carried out and we ordered a test 
for neoplasia, considering the possibility of parane-
oplastic pemphigus: lung function test with restric-
tive abnormalities. Chest CT scan with subpleural 
septal thickening, suspected because of the lingula 
lymphangitis, lower left lobe, as well as medium 
lobe and left and mediastinal and supraclavicular 
node enlargements There were also small bullous 
lesions in the genital and periungual areas when 
the new biopsy was carried out and we ordered 
tests for neoplasia, considering the possibility of 
paraneoplastic pemphigus: pulmonary function 
test with restrictive abnormalities. Chest CT scan 
showing subpleural septal thickening - which was 
suspected because of the lymphangitis on the 
lingula, lower left lobe, as well as the middle lobe 
and mediastinum and left supraclavicular nodal en-
largements. The digestive track endoscopy showed 
esophagus acanthosis and enanthematous gastritis.
Maintaining treatment, she enjoyed an 
important improvement in pain and no new le-
sions. After two-and-a-half months, she had only a 
small lesion on the left cheek mucosa. The results 
from the microscopy and immunohistochemistry 
suggested pemphigus vulgaris, and the direct 
immunofluorescence showed mild intercellular 
and intraepithelial granulous fluorescence, pre-
dominating in lower layers of the epithelium. 
The prednisone dose was then reduce to 40 mg/
day. She was worse on the third month of the 
disease, with enlargement of her neck volume and 
dyspnea, with new bullous lesions in her cheek 
mucosa, besides snoring and pulmonary sibilance.
She was admitted to the hospital and a 
pleural biopsy was carried out, which showed 
a carcinoma not well-differentiated (not the 
small-cell type) and, in a later biopsy of a level 
III neck lymph node on the right side, we defi-
ned a moderately differentiated adenocarcinoma 
(pulmonary metastasis).
She developed respiratory failure and 
was admitted to the ICU. She died on the fourth 
month of the disease.
DISCUSSION
Typical PNP clinical findings include un-
treatable stomatitis (more typical) and polymorphic 
skin lesions. Mucosal involvement is almost always 
present, ocular, oral, pharyngeal, laryngeal and/
or vulvar lesions4.
PNP histological findings include ke-
ratinocyte necrosis, intraepidermal acantholysis 
and vacuolar dermatitis on the interface. The 
immunofluorescence shows an IgG and comple-
ment deposits on the cell surface and, frequently, 
granular or linear complement deposits on the 
dermis-epidermis junction. The indirect immuno-
fluorescence shows circulating antibodies attached 
to the simple, columnar or transition epithelium, 
besides a typical pemphigus pattern. These auto-
antibodies suffer immunoprecipitation in a protein 
complex. This is the PNP diagnosis gold standard5.
Although this case did not have definitive 
laboratorial confirmation, the immunofluorescence 
showed a granular, intercellular, intraepithelial 
deposit, predominating in the lower layers of the 
epithelium - which is reported in the literature as 
a PNP characteristic.
FINAL REMARKS
The clinical presentation of the bullous 
lesions may be similar. This case was typical 
of paraneoplastic pemphigus without definitive 
laboratorial confirmation.
Thus, the importance of the proper diag-
nosis for the better treatment of this rare entity.
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Figure 1. Oroscopy - Bullous and ulcerated lesions on the cheek 
mucosa and palate.
